Werewolf Therapeutics Inc (HOWL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.63
• Market Cap: $31.07M
• EPS: $-1.62
• 52-Week High: $2.38
• 52-Week Low: $0.53

Market Sentiment

Werewolf Therapeutics Inc currently has a Neutral sentiment score of -0.03.

About Werewolf Therapeutics Inc

Werewolf Therapeutics, Inc. (HOWL) is an innovative biopharmaceutical company focused on developing next-generation immune-based therapies for cancer treatment. Headquartered in Cambridge, Massachusetts, the company utilizes its proprietary platform to engineer novel therapeutics that enhance the body’s immune response against tumors. With a robust pipeline of product candidates targeting a range of oncology indications, Werewolf Therapeutics is well-positioned to advance its mission of impro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Werewolf Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HOWL pay dividends?

Werewolf Therapeutics Inc (HOWL) does not currently pay a regular dividend.

What is HOWL's market cap?

Werewolf Therapeutics Inc (HOWL) has a market capitalization of $31.07M with a current stock price of $0.63.